These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16608112)

  • 21. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of fast-acting adaptogens and symptomatic means during evacuation of trauma victims by air transportation].
    Grechko AT; Glaznikov LA
    Aviakosm Ekolog Med; 1997; 31(2):47-9. PubMed ID: 9190256
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application of nootropic agents in complex treatment of patients with concussion of the brain].
    Tkachev AV
    Lik Sprava; 2007; (5-6):82-5. PubMed ID: 18418926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Piracetam treatment in ischemic stroke].
    Tomczykiewicz K; Domzał T
    Neurol Neurochir Pol; 1997; 31(6):1101-9. PubMed ID: 9591298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
    Zavadenko NN; Guzilova LS
    Neurosci Behav Physiol; 2009 May; 39(4):323-8. PubMed ID: 19340573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating dementia patients with vascular lesions with donepezil: a preliminary analysis.
    Thomas DA; Libon DJ; Ledakis GE
    Appl Neuropsychol; 2005; 12(1):12-8. PubMed ID: 15788218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
    Rodda J; Carter J
    Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R
    MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 30. [Piracetam, nimodipine and tacrine in the pharmacologic treatment of dementia: bibliographic review].
    Ojer Tsakiridu D; Dosantos Hernández JO; Larrabe Medina J; Sánchez Casado JI; Sologuren Echenagusia A
    Aten Primaria; 1996 Sep; 18(5):257-60, 262-4. PubMed ID: 8936720
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cerebrolysin in neurological and psychiatric practice].
    Vilenskiĭ BS
    Lik Sprava; 1997; (6):139-42. PubMed ID: 9589960
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of pseudotumorous course of brain demyelinating disease].
    Kislitsyn IuV; Cheremisinov OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):61-3. PubMed ID: 15822744
    [No Abstract]   [Full Text] [Related]  

  • 33. Piracetam for Sialorrhea in 2 Children With Intellectual Disability.
    Bozkurt H
    J Clin Psychopharmacol; 2015 Oct; 35(5):621-2. PubMed ID: 26252441
    [No Abstract]   [Full Text] [Related]  

  • 34. [New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].
    Medvedev VE; Frolova VI; Epifanov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):30-7. PubMed ID: 25403298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of shuizhitong capsule in treating senile vascular dementia].
    Fan XZ; Yang BL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Aug; 24(8):694-7. PubMed ID: 15366590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dyslexia: clinical, neurophysiological and neuropsychological manifestations during the treatment with nootropil].
    Zavadenko NN; Rumiantseva MV; Tolstova VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):36-42. PubMed ID: 19491817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
    Mateo D; Giménez-Roldán S
    Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Donepezil in Alzheimer's disease and vascular dementia].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):71-5. PubMed ID: 24073452
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of galantamine to treat vascular dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Lancet; 2002 Nov; 360(9344):1512-3; author reply 1513. PubMed ID: 12433549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.